FENNEC PHARMACEUTICALS INC. — Director's Dealing 2021

Dec 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2021-12-20

Reporting Person: Raykov Rosty (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-20	Stock Option (right to buy)	$4.08	A	300000	Acquired	2031-12-20	Common Shares (300000)	Direct

Footnotes

F1: On December 20, 2021, Rostislav Raykov was granted an incentive stock option to purchase 300,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F2: Item vests 100% upon FDA approval of PEDMARKTM.